insights_auto
Why is AGIO up 5.35%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
$33.00
arrow_upward
+5.35%(+1.67) 1D
Oct 19, 11:21:04 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
$31.61
High
$33.12
Low
$31.61
Mkt. cap
1.97B
Avg. vol.
1.09M
Volume
270.00K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$7.01
Beta
0.63
Shares outstanding
59.70M
No. of employees
540
Open
$31.61
High
$33.12
Low
$31.61
Mkt. cap
1.97B
Avg. vol.
1.09M
Volume
270.00K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$7.01
Beta
0.63
Shares outstanding
59.70M
No. of employees
540
News stories
From web sources and news partners
https://www.dars.gov.et/
·
2 weeks ago
Agios Pharmaceuticals (AGIO) Slides 2.09% to $31.80 as Shares Drift Toward Key Support - Volume Weighted Price
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc